Primary Rodent Production Support Center

美国国家癌症研究所（NCI）管理着一个生产实验室动物的计划，以支持许多NCI/NIH癌症研究活动。这些包括NIH校园实验室，NCI/NIH资助的研究承包商，NCI/NIH资助的受赠者，其他政府机构以及国外的合作者。动物生产项目由癌症治疗和诊断部（DCTD）发育治疗项目（DTP）生物学试验分支（BTB）管理。生产基因确定和无病原体的实验室动物需要严格的屏障建设和隔离操作，以提供所需的动物质量。为了尽量减少实验研究中的变量，这项工作的质量至关重要。生产最高质量的无病原微生物的啮齿动物是这项工作的主要目标。提供动物是为了支持癌症、传染病、生物恐怖主义威胁和其他国家认可的健康问题的病因和治疗研究。

The National Cancer Institute (NCI) administers a program to produce laboratory animals in support of many NCI/NIH cancer research activities. These include NIH on-campus laboratories, NCI/NIH-funded research contractors, NCI/NIH-funded grantees, other governmental agencies as well as collaborators in foreign countries. The Animal Production Program is managed by the Biological Testing Branch (BTB), Developmental Therapeutics Program (DTP), Division of Cancer Treatment and Diagnosis (DCTD). The production of genetically-defined and pathogen-free laboratory animals requires strict barrier building and isolator operations to provide the required quality of animals. The quality of this effort is of critical importance in order to minimize variables within experimental studies. The production of the highest quality rodents free from pathogenic organisms is the primary objective of this effort. Animals are provided to support research in the cause and treatment of cancer, infectious disease, bioterrorism threat and other nationally recognized health issues.